Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, et al.
Pharmacological Research (2021) Vol. 172, pp. 105840-105840
Open Access | Times Cited: 493

Showing 1-25 of 493 citing articles:

Ruminococcus gnavus: friend or foe for human health
Emmanuelle H. Crost, Erika Coletto, Andrew Bell, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 140
Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders
Somarani Dash, Yasir Ahmed Syed, Mojibur R. Khan
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 102
Brain-spleen axis in health and diseases: A review and future perspective
Wei Yan, Tong Wang, Lei Liao, et al.
Brain Research Bulletin (2022) Vol. 182, pp. 130-140
Open Access | Times Cited: 84
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 78
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications
Sonia Facchin, Luisa Bertin, Erica Bonazzi, et al.
Life (2024) Vol. 14, Iss. 5, pp. 559-559
Open Access | Times Cited: 48
Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design
Yi Cheng, Guohua Tan, Qihui Zhu, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 43
Antibiotics and the gut microbiome: Understanding the impact on human health
Rahul Harikumar Lathakumari, K.V. Leela, Abhishek Satheesan, et al.
Medicine in Microecology (2024) Vol. 20, pp. 100106-100106
Open Access | Times Cited: 25
Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome
Yu-Rim Chae, Yu Ra Lee, Young‐Soo Kim, et al.
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 4, pp. 747-756
Open Access | Times Cited: 21
Exposure to prescribed medication in early life and impacts on gut microbiota and disease development
Huan Huang, Jiayin Jiang, Xinyu Wang, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102428-102428
Open Access | Times Cited: 20
Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder
Cong-Ya Chen, Yufei Wang, Lan Lei, et al.
Life Sciences (2024) Vol. 351, pp. 122815-122815
Closed Access | Times Cited: 19
Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature
Ana Isabel Beltrán-Velasco, Manuel Reiriz, Sara Uceda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3010-3010
Open Access | Times Cited: 17
Neuroinflammation and Schizophrenia: New Therapeutic Strategies through Psychobiotics, Nanotechnology, and Artificial Intelligence (AI)
Freiser Eceomo Cruz Mosquera, Maria Camila Guevara-Montoya, Valentina Serna-Ramirez, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 391-391
Open Access | Times Cited: 15
Probiotics and Food Bioactives: Unraveling Their Impact on Gut Microbiome, Inflammation, and Metabolic Health
Alice Njolke Mafe, Great Iruoghene Edo, Patrick Othuke Akpoghelie, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 5
A review on probiotics and dietary bioactives: Insights on metabolic well-being, gut microbiota, and inflammatory responses
Alice Njolke Mafe, Great Iruoghene Edo, Osamah S. Majeed, et al.
Food Chemistry Advances (2025) Vol. 6, pp. 100919-100919
Open Access | Times Cited: 3
Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder
Javier R. Caso, Karina S. MacDowell, Ana González‐Pinto, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 67
The Microbiota–Gut–Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect
Fangyuan Zhu, Huaijun Tu, Tingtao Chen
Nutrients (2022) Vol. 14, Iss. 10, pp. 2081-2081
Open Access | Times Cited: 55
Effect of Probiotics on Psychiatric Symptoms and Central Nervous System Functions in Human Health and Disease: A Systematic Review and Meta-Analysis
Charlotte Le Morvan de Sequeira, Charlotte Hengstberger, Paul Enck, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 621-621
Open Access | Times Cited: 53
Limosilactobacillus reuteri in Health and Disease
Jumana Abuqwider, Mohammad Altamimi, Gianluigi Mauriello
Microorganisms (2022) Vol. 10, Iss. 3, pp. 522-522
Open Access | Times Cited: 50
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 45
A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide
Xiaojin Liu, Luodan Yang, Guangyao Li, et al.
International Journal of Biological Macromolecules (2022) Vol. 229, pp. 168-180
Closed Access | Times Cited: 43
Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice
Heng Fang, Yirong Wang, Jia Deng, et al.
mSystems (2022) Vol. 7, Iss. 3
Open Access | Times Cited: 41
Early life adversity as a risk factor for cognitive impairment and Alzheimer’s disease
Zhihai Huang, J. Dedrick Jordan, Quanguang Zhang
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 39
The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Salvatore Chirumbolo, et al.
Pharmacological Research (2023) Vol. 192, pp. 106799-106799
Open Access | Times Cited: 39
The Alleviation of Gut Microbiota-Induced Depression and Colitis in Mice by Anti-Inflammatory Probiotics NK151, NK173, and NK175
Jong-Wook Yoo, Yoon-Jung Shin, Xiaoyang Ma, et al.
Nutrients (2022) Vol. 14, Iss. 10, pp. 2080-2080
Open Access | Times Cited: 38
Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies
Liping Liu, Qin Wu, Yuping Chen, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109685-109685
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top